Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates
JM Stinnett, R Pendleton, LA Skordos… - American journal of …, 2005 - Wiley Online Library
Venous thromboembolism (VTE) is common but often unrecognized in medically ill patients.
Over the past 5 years, three large‐scale placebo‐controlled trials enrolling a total of 5500 …
Over the past 5 years, three large‐scale placebo‐controlled trials enrolling a total of 5500 …
Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates
JM Stinnett, R Pendleton, L Skordos… - American journal …, 2005 - pubmed.ncbi.nlm.nih.gov
Venous thromboembolism (VTE) is common but often unrecognized in medically ill patients.
Over the past 5 years, three large-scale placebo-controlled trials enrolling a total of 5500 …
Over the past 5 years, three large-scale placebo-controlled trials enrolling a total of 5500 …
[引用][C] Venous thromboembolism prophylaxis in medically III patients and the development of strategies to improve prophylaxis rates
JM STINNETT, R PENDLETON… - American journal of …, 2005 - pascal-francis.inist.fr
Venous thromboembolism prophylaxis in medically III patients and the development of
strategies to improve prophylaxis rates CNRS Inist Pascal-Francis CNRS Pascal and …
strategies to improve prophylaxis rates CNRS Inist Pascal-Francis CNRS Pascal and …
Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates.
JM Stinnett, R Pendleton, L Skordos… - American Journal of …, 2005 - europepmc.org
Venous thromboembolism (VTE) is common but often unrecognized in medically ill patients.
Over the past 5 years, three large-scale placebo-controlled trials enrolling a total of 5500 …
Over the past 5 years, three large-scale placebo-controlled trials enrolling a total of 5500 …